Strategy

Fix Price Company Review: first half results 2021 of the year

Fix Price Group Ltd. (MCX: FIXP) — international network of fixed price discounters, registered in Cyprus, but leading business in the countries of the former USSR both in the form of its own stores, as well as franchising. In the Russian fixed price retail market, the company occupies a position, close to monopoly.

Few want to play against Katie Wood

Katie wood, as known, not critically short. However, the new ETF, betting against her tech fund, does not arouse interest among investors yet – even though, what the strategy has brought in the first few days 2,8% arrived.

Barrick Gold Review: the second gold miner in the world

Barrick Gold Corporation (NYSE: GOLD) is one of the world leaders in the gold mining industry, which works in 13 countries of the world, produces approximately 4.5 million ounces of gold per year and has a total reserve of about 68 million ounces..

Heron Therapeutics Review: solutions for oncology and postoperative recovery

Heron Therapeutics (NASDAQ: HRTX) - San Diego-based biotechnology company, founded in the USA in 1983. Business is focused on helping patients, undergoing chemotherapy, and relief of postoperative pain. In the distant past, the company's shares were more expensive 1000 $ for pike, and now dropped to 10-12 $. Where the money comes from Commercial business strategy is focused on addressing the unmet needs of different groups of patients and is now engaged in research in the field of oncology and surgery.. The company has already brought several drugs to the U.S. market to relieve postoperative pain and relieve symptoms., caused by different courses of chemotherapy. Product Development Portfolio To date, Heron Therapeutics has successfully commercialized three of its products. Zynrelef. For the first time 72 hours relieves pain in adult patients, who have undergone major knee surgery. Approved by the Food and Drug Administration (FDA) 1 July 2021 and became an alternative to traditional opioids, the use of which is associated with the risk of addiction. Approved in 31 European country. Cinvanti and Sustol. Drugs for adult patients with cancer. Prevents nausea & vomiting, caused by the passage of primary and repeated courses of chemotherapy of varying degrees of aggressiveness. The company has two drugs for adults at the clinical stage of development: HTX-034 to relieve postoperative pain in the first 5-7 days and HTX-019, which prevents bouts of nausea and vomiting in patients, who have undergone surgery. For the latter, it is planned to apply for FDA approval in the fourth quarter of 2021.. Что плохого Коронавирус наносит ответный удар. Last year, the pandemic and lockdowns significantly hurt the company's business.: medical facilities were closed and patients simply could not get their appointments from doctors., prescription drug manufacturers suffered losses. Сейчас ситуация с вакцинацией и мерами профилактики

Heron Therapeutics Review: solutions for oncology and postoperative recovery Read more

How to get around the risks of stagflation? Three investment strategies

Economy, stagflationary, Is the economy, in which there is simultaneously stagnation of activity and acceleration of inflation. This phenomenon was first noted in the 1970s., when the oil shock led to a prolonged period of price increases, but at the same time, GDP growth dropped sharply.

How to get around the risks of stagflation? 3 investment strategies

Economy, stagflationary, Is the economy, in which there is simultaneously stagnation of activity and acceleration of inflation. This phenomenon was first noted in the 1970s., when the oil shock led to a prolonged period of price increases, but at the same time, GDP growth dropped sharply.

5 investor nightmares

Hello everybody! I am with you again with interesting and useful posts about investments! Today I want to write about 5 terrible scenarios, which can negate all the efforts of the investor.

New securities on the Moscow Exchange in October 2021

New bonds of Russian companies began trading on the Moscow Exchange in October, shares of the Renaissance Insurance group, as well as shares of 80 foreign companies at once. There are also new exchange-traded mutual funds. Part of the new bonds we do not mention.

American Outdoor Brands Review: insiders get ready for camping

American Outdoor Brands (NASDAQ: AUGUST) - American manufacturer of sports weapons and recreational equipment, which was spun off as a separate business in 2020. Recently, insiders have become interested in the company and decided to buy its shares - this is often a good indicator of future profitability..

Scroll to Top